• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,909.39 583.15
(1.11%)
Dow Jones
7,503.05 -1.18
(-0.02%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
94.99 0.39
(0.42%)
EUR-INR
108.21 0.30
(0.28%)
GBP-INR
125.93 0.66
(0.53%)
JPY-INR
0.58 0.00
(0.27%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
132.2958859
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
45.08
40927.65
EPS(TTM)
Face Value()
Div & Yield %
53.59
10
2.36
 

SVA India reports consolidated net loss of Rs 1.20 crore in the March 2026 quarter
Jun 02,2026
Net Loss of SVA India reported to Rs 1.20 crore in the quarter ended March 2026 as against net loss of Rs 0.87 crore during the previous quarter ended March 2025. Sales rose 273.68% to Rs 0.71 crore in the quarter ended March 2026 as against Rs 0.19 crore during the previous quarter ended March 2025.

For the full year,net profit rose 1.89% to Rs 1.62 crore in the year ended March 2026 as against Rs 1.59 crore during the previous year ended March 2025. Sales rose 46.05% to Rs 1.11 crore in the year ended March 2026 as against Rs 0.76 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.710.19 274 1.110.76 46
OPM %-70.42-131.58 --180.18-53.95 -
PBDT-0.93-0.64 -45 -2.740.85 PL
PBT-0.93-0.65 -43 -2.750.85 PL
NP-1.20-0.87 -38 1.621.59 2